Crossmark

Diffusion-weighted magnetic resonance imaging using a preclinical 1 T PET/MRI in healthy and tumor-bearing rats

Crossref DOI link: https://doi.org/10.1186/s13550-019-0489-6

Published Online: 2019-02-22

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Albrecht, Jakob https://orcid.org/0000-0003-1684-6302
Polenz, Dietrich

Kühl, Anja A.

Rogasch, Julian M. M.

Leder, Annekatrin

Sauer, Igor M.

Babos, Magor

Mócsai, Gabor

Beindorff, Nicola

Steffen, Ingo G.

Brenner, Winfried

Koziolek, Eva J.
Funding

Funding for this research was provided by:

ZIM Kooperationsprojekt - AiF Projekt GmbH - Projektträger des BMWi (not applicable)

German Cancer Consortium (not applicable)
License Information

Text and Data Mining valid from 2019-02-22
More Information

Article History

Received: 16 November 2018

Accepted: 8 February 2019

First Online: 22 February 2019

Ethics approval and consent to participate

: All animal experiments were performed in accordance with national and local guidelines for animal welfare and were approved by the animal ethics committee of the state Berlin (LAGeSo, Reg. No. G0059/14).

: Not applicable.

: The authors MB and GM work for Mediso Ltd., the company that has developed the nanoScan PET/MRI we used in this study. The other authors have no conflicts of interest to declare.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.